We are live on ! Find out more
XENT

Intersect ENT, Inc

Delisted

XENT was delisted on the 12th of May, 2022.

120 hedge funds and large institutions have $776M invested in Intersect ENT, Inc in 2019 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 42 increasing their positions, 40 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

654% more call options, than puts

Call options by funds: $22.3M | Put options by funds: $2.95M

83% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 12

49% more capital invested

Capital invested by funds: $521M → $776M (+$255M)

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

7% more funds holding

Funds holding: 112120 (+8)

5% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 40

Holders
120
Holders Change
+8
Holders Change %
+7.14%
% of All Funds
2.36%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.08%
New
22
Increased
42
Reduced
40
Closed
12
Calls
$22.3M
Puts
$2.95M
Net Calls
+$19.3M
Net Calls Change
+$6.24M
Name Holding Trade Value Shares
Change
Change in
Stake
LI
126
Leap Investments
Illinois
-$296K -17,400 Closed
HSBC Holdings
127
HSBC Holdings
United Kingdom
-$264K -15,546 Closed
Nisa Investment Advisors
128
Nisa Investment Advisors
Missouri
-$208K -12,230 Closed
WCM
129
Weld Capital Management
New York
-$185K -10,869 Closed
QT
130
Quantamental Technologies
New York
-$78K -4,581 Closed
TRCT
131
Tower Research Capital (TRC)
New York
-$15.9K -786 -100%
Fidelity Investments
132
Fidelity Investments
Massachusetts
-$41 -2 -50%

XENT Hedge Fund Activity: Q4 2019 in Review

120 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q4 2019, worth a combined $776M — up 49% from $521M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new XENT positions and 12 closed out — a net gain of 10 holders — while 42 added to existing stakes and 40 trimmed.

The largest buyer was Polar Capital, opening a new position worth an estimated $7.4M. The largest seller was Point72 Asset Management, cutting an estimated $9.23M.

  • 120 institutional investors held Intersect ENT, Inc (XENT) as of Q4 2019, up from 112 in Q3 2019.
  • Funds reported $776M of Intersect ENT, Inc stock for Q4 2019, up 49% quarter-over-quarter.
  • 22 funds opened new Intersect ENT, Inc positions in Q4 2019 and 12 closed out, a net change of +10 holders.
  • The largest Intersect ENT, Inc buyer in Q4 2019 was Polar Capital, an estimated $7.4M added.
  • The largest Intersect ENT, Inc seller in Q4 2019 was Point72 Asset Management, an estimated $9.23M sold.

Based on aggregated 13F filings for Q4 2019.